Medical News

RSS

Proteacel acquires exclusive rights to PORE technology from Moffitt Cancer Center

Moffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE™ technology for delivery of genes into cells.

18 Mar 2010

CBO is straining under the weight of health care requests

The Congressional Budget Office is feeling the strain of dealing with the high-profile requests for scoring health care legislation as Democrats move toward releasing a reconciliation bill, "a stressor that may have contributed to the recent incorrect scoring of a draft House provision," Politico reports.

18 Mar 2010

States weigh taxes to help fund Medicaid—and raise federal contributions

Reporting for Kaiser Health News, Andy Miller looks at four states -- Georgia, Wisconsin, Iowa and Tennessee -- that are weighing new taxes on hospitals to help finance their beleaguered Medicaid programs.

18 Mar 2010

Babies born with severe cleft palates: Promising breakthrough without complex surgery

Scientists working on a treatment for babies born with cleft palates have made a promising breakthrough and the first clinical trials are planned for early next year. Clefts are the most common birth defect in Britain, with one in every 700 babies affected; currently in severe cases radical surgery is required to correct the problem, and in addition future complications can occur as the child grows into an adult.

18 Mar 2010

Gene regulation rather than genes make us unique

Once the human genome was sequenced in 2001, the hunt was on for the genes that make each of us unique. But scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and Yale and Stanford Universities in the USA, have found that we differ from each other mainly because of differences not in our genes, but in how they're regulated - turned on or off, for instance.

18 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

ISCO commences second phase of testing RPE derived from parthenogenetic stem cells

International Stem Cell Corporation, announced today that ISCO's Research and Therapeutic Development Group, together with a group of scientists from the University of California, Irvine (UCI), is starting a second phase of essential pre-clinical experiments to test retinal pigment epithelium derived from parthenogenetic stem cells. Follow on pre-clinical experiments will be conducted to rescue vision in disease models.

18 Mar 2010

Meta-study: Seven health risks impair academic performance of urban minority youth

"Educationally relevant health disparities" are key drivers of the achievement gap, "but they are largely overlooked," Charles Basch, the Richard March Hoe Professor of Health Education at Teachers College, Columbia University, said at a recent panel discussion at the College.

18 Mar 2010

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

NewCardio, Inc., a cardiac diagnostic technology provider, announced today that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio's QTinno™ software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies.

18 Mar 2010

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

Humedica, a next-generation clinical informatics company, and Anceta, the healthcare informatics subsidiary of the American Medical Group Association, today announced the launch of Humedica MinedShare™ Ambulatory as well as AMGA’s Anceta Collaborative Data Warehouse at the AMGA 2010 Annual Conference, taking place now through March 20 in New Orleans.

18 Mar 2010

StemCells granted UK patent covering true rat stem cells and genetically engineered rats

StemCells, Inc. announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with broad claims covering true (germline competent) rat stem cells and genetically engineered rats derived from these cells. The patented technology is expected to have significant utility to academic and pharmaceutical industry researchers by enabling them to create novel rat models for the study of human diseases. Both mice and rats are used by scientists to model various human diseases.

18 Mar 2010

Solos Endoscopy secures U.S. Trademark for MammoView name

Solos Endoscopy, Inc. is pleased to announce the Company has secured the U.S. Trademark for the MammoView® name. The MamoView® Breast Endoscopy System offers a state-of-the-art endoscopic technology for detecting early stage breast cancer. The Company's Breast Endoscopy System employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of breast cancers arise.

18 Mar 2010

Harden Healthcare receives $31.5M as part of $145M senior secured credit facility

GE Capital, Healthcare Financial Services has provided $31.5 million as part of a $145 million senior secured credit facility for Harden Healthcare, LLC. Harden will use the proceeds of the financing to provide additional growth capital and to refinance its existing debt facilities. GE Capital is the administrative agent for the credit facility. GE Capital Markets served as co-lead arranger and joint bookrunner.

18 Mar 2010

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.

18 Mar 2010

SGH recognized as winner of Microsoft HUG 2010 Innovation Awards

Eclipsys Corporation®, The Outcomes Company®, today announced that Singapore General Hospital, Singapore’s oldest and largest acute tertiary hospital and national referral center, has been recognized as a winner of the Microsoft HUG 2010 Innovation Awards in the category of “Best Use of Clinical Records — Inpatient.”

18 Mar 2010

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, announced today its financial results for the fourth quarter and full year 2009, and the filing of its Annual Report on Form 10-K with the Securities and Exchange Commission.

18 Mar 2010

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

A group of Argentine scientists, including health experts from the Wildlife Conservation Society, have announced that yellow fever is the culprit in a 2007-2008 die-off of howler monkeys in northeastern Argentina, a finding that underscores the importance of paying attention to the health of wildlife and how the health of people and wild nature are so closely linked.

18 Mar 2010

Southern California’s Sexual Recovery Institute introduces additional Intensive Outpatient Programs

Southern California’s Sexual Recovery Institute (SRI), the leading outpatient treatment center for sex addiction, has announced additional Intensive Outpatient Programs (IOP). The expansion is a result of increased awareness of sex addiction issues as the mainstream media begins to shed light on high profile scandals and subsequent treatment methods.

18 Mar 2010

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Manitobans with wet age-related macular degeneration (AMD) received a dose of good news. The Manitoba government announced that Lucentis (ranibizumab injection) will soon be funded through a centralized vision program, effective June 1, 2010.

18 Mar 2010

Healthcare Reform: Congressman Chaka Fattah calls for single up-or-down vote

Congressman Chaka Fattah (D-PA) issues the following statement calling for a single up-or-down vote on Healthcare Reform:

18 Mar 2010

Medical News

Proteacel acquires exclusive rights to PORE technology from Moffitt Cancer Center

CBO is straining under the weight of health care requests

States weigh taxes to help fund Medicaid—and raise federal contributions

Babies born with severe cleft palates: Promising breakthrough without complex surgery

Gene regulation rather than genes make us unique

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

ISCO commences second phase of testing RPE derived from parthenogenetic stem cells

Meta-study: Seven health risks impair academic performance of urban minority youth

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

StemCells granted UK patent covering true rat stem cells and genetically engineered rats

Solos Endoscopy secures U.S. Trademark for MammoView name

Harden Healthcare receives $31.5M as part of $145M senior secured credit facility

Novelos Therapeutics Phase 3 trial of NOV-002 in advanced NSCLC fails to meet primary and secondary endpoints

SGH recognized as winner of Microsoft HUG 2010 Innovation Awards

ZIOPHARM Oncology reports fourth quarter net income of $1.0M against loss last year

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

Southern California’s Sexual Recovery Institute introduces additional Intensive Outpatient Programs

Manitoba government: AMD drug Lucentis will be funded through centralized vision program

Healthcare Reform: Congressman Chaka Fattah calls for single up-or-down vote

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News